Oncolytics Biotech
ONCY
$1.18
Share price
0.00%
Change (1 day)
-30.99%
Change (1 year)
Categories
Oncolytics Biotech (ONCY) - Total assets
Total assets on the balance sheet as of December 2023 : $29.32 M
According to Oncolytics Biotech 's latest financial reports the company's total assets are $29.32 M. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Oncolytics Biotech - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2023-12-31 | $29.32 M | 6.25% |
| 2022-12-31 | $27.59 M | -23.34% |
| 2021-12-31 | $36 M | 33.65% |
| 2020-12-31 | $26.93 M | 78.96% |
| 2019-12-31 | $15.05 M | 37.92% |
| 2018-12-31 | $10.91 M | -24.36% |
| 2017-12-31 | $14.42 M | 31.33% |
| 2016-12-31 | $10.98 M | -44.35% |
| 2015-12-31 | $19.74 M | 33.24% |
| 2014-12-31 | $14.81 M | -44.12% |
| 2013-12-31 | $26.51 M | 19.41% |
| 2012-12-31 | $22.2 M | -37.08% |
| 2011-12-31 | $35.28 M | -20.61% |
| 2010-12-31 | $44.45 M | 31.4% |
| 2009-12-31 | $33.82 M | 194.06% |
| 2008-12-31 | $11.5 M | -56.36% |
| 2007-12-31 | $26.36 M | -8.56% |
| 2006-12-31 | $28.82 M | -27.45% |
| 2005-12-31 | $39.73 M | 20.87% |
| 2004-12-31 | $32.87 M | 63.71% |
| 2003-12-31 | $20.08 M | 52.96% |
| 2002-12-31 | $13.12 M | -5.79% |
| 2001-12-31 | $13.93 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $63.94 B | 217,973.46% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $99.03 B | 337,636.17% | 🇺🇸 USA |
 Mirati Therapeutics MRTX | $1.12 B | 3,752.77% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | $37.01 M | 26.24% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $43.47 B | 148,181.15% | 🇮🇱 Israel |
 AVEO Oncology
AVEO | $0.10 B | 245.25% | 🇺🇸 USA |